Millennium Management’s PAVmed PAVM Stock Holding History

Millennium Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-73	Closed	-$9.69K	–	6410
2023 Q3	$9.69K	Sell	73 -135	-65%	-$20.9K	﹤0.01%	5767
2023 Q2	$38.2K	Sell	208 -282	-58%	-$56.4K	﹤0.01%	5525
2023 Q1	$82K	Sell	490 -234	-32%	-$49.3K	﹤0.01%	5485
2022 Q4	$156K	Sell	724 -121	-14%	-$45.7K	﹤0.01%	5422
2022 Q3	$327K	Sell	845 -2,680	-76%	-$1.52M	﹤0.01%	5295
2022 Q2	$1.48M	Buy	+3,525	New	+$1.7M	﹤0.01%	4003
2022 Q1	–	Sell	-808	Closed	-$895K	–	7326
2021 Q4	$895K	Buy	808 +732	+963%	+$1.59M	﹤0.01%	4514
2021 Q3	$293K	Buy	+76	New	+$240K	﹤0.01%	5835
2021 Q2	–	Sell	-857	Closed	-$1.71M	–	6948
2021 Q1	$1.71M	Buy	+857	New	+$1.29M	﹤0.01%	3680
2018 Q4	–	Sell	-55	Closed	-$32K	–	4069
2018 Q3	$32K	Buy	+55	New	+$33.6K	﹤0.01%	3817
2018 Q1	–	Sell	-46	Closed	-$47K	–	3971
2017 Q4	$47K	Sell	46 -43	-48%	-$75.7K	﹤0.01%	3724
2017 Q3	$218K	Buy	+89	New	+$184K	﹤0.01%	3202

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Millennium Management's PAVM Position: Q4 2023 in Review

Millennium Management sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 73 shares — an estimated $9.69K sold.

Millennium Management first reported a position in PAVM in Q3 2017 and held it in 12 quarters. The position peaked at $1.71M in Q1 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

Millennium Management reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
Millennium Management sold 73 PAVmed shares in Q4 2023, an estimated $9.69K.
Millennium Management first reported a position in PAVmed in Q3 2017 and held it in 12 quarters.
Millennium Management's PAVmed position peaked at $1.71M in Q1 2021.
23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.